Literature DB >> 19286745

Number of global clinical trials done in UK fell by two thirds after EU directive.

Anne Gulland.   

Abstract

Mesh：

Year:  2009        PMID： 19286745     DOI： 10.1136/bmj.b1052

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

Review 2.  Investigator-initiated trials of targeted oncology agents: why independent research is at risk?

Authors:  L Bergmann; B Berns; A G Dalgleish; M von Euler; T T Hecht; G L Lappin; N Reed; S Palmeri; J Smyth; S Embacher-Aichorn; H Zwierzina
Journal:  Ann Oncol       Date:  2010-02-04       Impact factor: 32.976

3.  Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials.

Authors:  James Raftery; Eleanor Fairbank; Lisa Douet; Louise Dent; Alison Price; Ruairidh Milne; Tom Walley
Journal:  Trials       Date:  2012-08-20       Impact factor: 2.279

4.  Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study.

Authors:  Derek J Ward; Edward Hammond; Luan Linden-Phillips; Andrew J Stevens
Journal:  BMJ Open       Date:  2015-11-16       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.